CUTANEOUS LEISHMANIASIS IN INDIA - CLINICAL-EXPERIENCE WITH ITRACONAZOLE (R51-211 JANSSEN)

被引：54

作者：

DOGRA, J ^{[1
]}

ANEJA, N ^{[1
]}

LAL, BB ^{[1
]}

MISHRA, SN ^{[1
]}

机构：

[1] SP MED COLL,DEPT MED & DERMATOL,BIKANER,INDIA

来源：

INTERNATIONAL JOURNAL OF DERMATOLOGY | 1990年 / 29卷 / 09期

关键词：

D O I：

10.1111/j.1365-4362.1990.tb02593.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Abstract: Fifteen patients with cutaneous leishmaniasis were randomly selected for clinical trials with itraconazole. A single daily itraconazole dose of approximately 4 mg per 1 kg of body weight was administered to each patient with breakfast for 6 weeks. Five patients served as controls. On completion of therapy, ten cases in the study group (66.6%) were considered to be cured. No major adverse effects were reported. No significant changes were seen in the controls at the end of the study. The possibility of spontaneous recovery will be discussed in this report even though it is considered to be unlikely. Itraconazole has promising potential in cutaneous leishmaniasis therapy. Copyright © 1990, Wiley Blackwell. All rights reserved

引用

页码：661 / 662

页数：2

共 11 条

[1]

BORELLI D, 1987, REV INFECTIOUS DI S1, V9, P57

[2] THERAPY OF TROPICAL SKIN DISEASES [J].